About
Personalized Vaccines
Areas of Focus
Categories
VaccineChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
0
As Collaborator
6
Total Enrollment
235
By Phase
NA: 6
By Status
RECRUITING: 3UNKNOWN: 2COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06353646Collaborator
XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
NARecruiting
24 participants
Started: Mar 12, 2024 · Completed: Dec 31, 2026
NCT05940181Collaborator
A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors
NARecruiting
9 participants
Started: Mar 1, 2023 · Completed: Dec 31, 2025
NCT05359354Collaborator
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors
NARecruiting
36 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
NCT05227378Collaborator
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer
NAUnknown
36 participants
Started: Mar 31, 2022 · Completed: Aug 31, 2025
NCT05192460Collaborator
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer
NAUnknown
30 participants
Started: Mar 28, 2022 · Completed: Jun 30, 2025
Locations (1)
Headquarters
Beijing, China
Map
Loading map...